Literature DB >> 1945876

Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates).

W J Stec1, A Grajkowski, M Koziolkiewicz, B Uznanski.   

Abstract

The synthesis and separation of diastereoisomerically pure 5'-O-DMT-nucleoside 3'-O-(2-thio-1,3,2-oxathiaphospholane) allows their use as synthons in DBU-catalyzed reaction with the 5'-hydroxyl function of solid-support-bound nucleoside moiety. Since this reaction is stereospecific (greater than 99%), this novel method allows preparation of oligo(nucleoside phosphorothioates) with predetermined chirality at each P-chiral internucleotide phosphorothioate centre.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945876      PMCID: PMC329042          DOI: 10.1093/nar/19.21.5883

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  10 in total

1.  Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.

Authors:  A Bielinska; R A Shivdasani; L Q Zhang; G J Nabel
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

2.  Stereochemical course of the reaction catalyzed by 5'-nucleotide phosphodiesterase from snake venom.

Authors:  F R Bryant; S J Benkovic
Journal:  Biochemistry       Date:  1979-06-26       Impact factor: 3.162

3.  Solid-phase synthesis of oligoribonucleotides using 9-fluorenylmethoxycarbonyl (Fmoc) for 5'-hydroxyl protection.

Authors:  C Lehmann; Y Z Xu; C Christodoulou; Z K Tan; M J Gait
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

4.  Absolute configuration of the diastereomers of adenosine 5'-O-(1-thiotriphosphate): consequences for the stereochemistry of polymerization by DNA-dependent RNA polymerase from Escherichia coli.

Authors:  P M Burgers; F Eckstein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Stereospecific synthesis of thymidine cyclic 3',5'-(Sp)-and (Rp)-phosphorothioates.

Authors:  W S Zielinski; W J Stec
Journal:  J Am Chem Soc       Date:  1977-12-07       Impact factor: 15.419

6.  Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.

Authors:  M Matsukura; G Zon; K Shinozuka; M Robert-Guroff; T Shimada; C A Stein; H Mitsuya; F Wong-Staal; J S Cohen; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Authors:  M Matsukura; K Shinozuka; G Zon; H Mitsuya; M Reitz; J S Cohen; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  An approach to the stereoselective synthesis of Sp-dinucleoside phosphorothioates using phosphotriester chemistry.

Authors:  R Cosstick; D M Williams
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

10.  Synthesis and configurational analysis of a dinucleoside phosphate isotopically chiral at phosphorus. Stereochemical course of Penicillium citrum nuclease P1 reaction.

Authors:  B V Potter; B A Connolly; F Eckstein
Journal:  Biochemistry       Date:  1983-03-15       Impact factor: 3.162

  10 in total
  18 in total

Review 1.  Specific VDAC inhibitors: phosphorothioate oligonucleotides.

Authors:  C A Stein; Marco Colombini
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 2.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

3.  Solid support synthesis of all-Rp-oligo(ribonucleoside phosphorothioate)s.

Authors:  H Almer; J Stawinski; R Strömberg
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

4.  Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.

Authors:  Naoki Iwamoto; David C D Butler; Nenad Svrzikapa; Susovan Mohapatra; Ivan Zlatev; Dinah W Y Sah; Stephany M Standley; Genliang Lu; Luciano H Apponi; Maria Frank-Kamenetsky; Jason Jingxin Zhang; Chandra Vargeese; Gregory L Verdine
Journal:  Nat Biotechnol       Date:  2017-08-21       Impact factor: 54.908

5.  Inhibition of HTLV-I induction and virus-induced syncytia formation by oligodeoxynucleotides.

Authors:  N Miyano-Kurosaki; Y Koyanagi; M Mizuguchi; S Ohki; K Makino; N Yamamoto
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.

Authors:  T Shimayama; F Nishikawa; S Nishikawa; K Taira
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

7.  Synthesis of specific diastereomers of a DNA methylphosphonate heptamer, d(CpCpApApApCpA), and stability of base pairing with the normal DNA octamer d(TPGPTPTPTPGPGPC).

Authors:  E V Vyazovkina; E V Savchenko; S G Lokhov; J W Engels; E Wickstrom; A V Lebedev
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

8.  Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.

Authors:  L Benimetskaya; J L Tonkinson; M Koziolkiewicz; B Karwowski; P Guga; R Zeltser; W Stec; C A Stein
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

9.  Significance of stereochemistry of 3'-terminal phosphorothioate-modified primer in DNA polymerase-mediated chain extension.

Authors:  Barbara Nawrot; Natasha Paul; Beata Rebowska; Wojciech J Stec
Journal:  Mol Biotechnol       Date:  2008-09-04       Impact factor: 2.695

10.  Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.

Authors:  Y Huang; R Snyder; M Kligshteyn; E Wickstrom
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.